Cancer stem-like cells contribute to paclitaxel resistance in esophageal squamous cell carcinoma.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To examine the role of esophageal squamous cell carcinoma (ESCC) stem cells in paclitaxel resistance through the molecular characterization of ESCC stem cells.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Int J Clin Exp Pathol

Title: International journal of clinical and experimental pathology

Publisher:

ISSN (Electronic): 1936-2625

ISSN (Print): 1936-2625

Publication date (Electronic): 2022

Volume: 15

Issue: 4

Affiliations

[1 ] Department of Gastroenterology, Fukang Hospital Affiliated to Tibet University Lhasa, China.

[2 ] Department of Science and Education, People's Hospital of Tibet Autonomous Region, Tibet University Lhasa, China.

[3 ] Department of Laboratory, Fukang Hospital Affiliated to Tibet University Lhasa, China.

Article

PMC ID: 9077107

PubMed ID: 35535205

SO-VID: 8b67b47e-45d5-4b1f-8ff6-7702f42b9b75

History

Keywords: esophageal squamous cell carcinoma,Cancer stem-like cells,resistance,paclitaxel

Data availability:

Keywords: esophageal squamous cell carcinoma, Cancer stem-like cells, resistance, paclitaxel

Cancer stem-like cells contribute to paclitaxel resistance in esophageal squamous cell carcinoma.

Read this article at

Abstract

Related collections

Stress signalling in stem cells

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 643

Cited by 2